Haleos Labs Limited (BOM:540679)
India · Delayed Price · Currency is INR 1,521.00
-168.95 (-10.00%)
At close: Jun 2, 2026
Haleos Labs Market Cap
Haleos Labs has a market cap or net worth of 4.33 billion as of June 3, 2026. Its market cap has decreased by -1.47% in one year.
Market Cap
4.33B
Enterprise Value
5.57B
Revenue
3.36B
Ranking
n/a
PE Ratio
25.00
Stock Price
1,521.00
Market Cap Chart
Since August 17, 2017, Haleos Labs's market cap has increased from 407.69M to 4.33B, an increase of 961.70%. That is a compound annual growth rate of 30.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 4.37B | 9.06% |
| Dec 31, 2025 | 4.00B | 12.59% |
| Dec 31, 2024 | 3.56B | 122.05% |
| Dec 29, 2023 | 1.60B | -15.33% |
| Dec 30, 2022 | 1.89B | -14.48% |
| Dec 31, 2021 | 2.21B | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 6.33B |
| ZIM Laboratories | 5.48B |
| Jenburkt Pharmaceuticals | 5.12B |
| Albert David | 4.40B |
| Amanta Healthcare | 4.31B |
| Medico Remedies | 3.96B |
| Medicamen Biotech | 3.44B |
| Trident Lifeline | 2.97B |